This website uses cookies. By using the site you are agreeing to our Privacy Policy.

Dedicated to develop the regenerative medicine industry in Japan
Dedicated to develop the regenerative medicine industry in Japan

What kind of company is J-TEC?

J-TEC is a part of the Fujifilm group

PICK UP
  • Top Message
  • IR Library

WHAT'S NEW MORE

Jun. 26, 2019 Updated Top Message.
The Annual J-TEC Stockholders Meeting took place on June 25th, and the Meeting approved the new BOD members. Updated Corporate Profile.
Apr. 25, 2019 Released "FY2018 Financial Report".
Apr. 1, 2019 Updated Top Message.
Mar.20, 2019 Announcement of Application for Manufacturing and Marketing Approval for Cultured Autologous Corneal Epithelium (Development name: EYE-01M)
- First application for a regenerative medical product in the field of ophthalmology in Japan -
( PDF file 134KB)
Jan. 30, 2019 Released "Financial Report for the 3 rd Quarter of FY2018".
Jan. 7, 2019 Expansion of Indication for Autologous Cultured Epidermis “JACE”:
Dystrophic and Junctional Epidermolysis Bullosa ( PDF file 19.8KB)
Jan. 1, 2019 Updated Top Message.
Oct. 30, 2018 Updated Top Message.
Released "Financial Report for the 2 nd Quarter of FY2018".
Jul. 30, 2018 Released "Financial Report for the 1 st Quarter of FY2018"
Jul. 19, 2018 Toward Expansion of Indication to Include Secondary Knee Osteoarthritis from Trauma, Etc. Submission of CTN for Clinical Trial of Autologous Cultured Cartilage “JACC” ( PDF file 132KB)
Jul. 17, 2018 Eye Irritancy Testing Method using “LabCyte CORNEA-MODEL24” Human 3-Dimensional Cultured Corneal Epithelium Included in OECD Test Guideline ( PDF file 108KB)
Jul. 3, 2018 Submission of CTN for Clinical Trial of Autologous Cultured Epidermis with Melanocyte, “ACE02” for the Treatment of Leukoderma ( PDF file 131KB)
Jun. 27, 2018 Updated Top Message.
The Annual J-TEC Stockholders Meeting took place on June 26th, and the Meeting approved the new BOD members. Updated Corporate Profile.
Jun. 21, 2018 Japan Tissue Engineering, Nagoya University, and Shinshu University
sign patent license agreement for the development of a low-cost manufacturing technology for autologous CAR-T cell therapy with enhanced targeting efficiency against CD 19-positive acute lymphoblastic leukemia ( PDF file 236KB)
Apr. 26, 2018 Released "FY2017 Financial Report".
Apr. 2, 2018 Updated Top Message.
Jan. 30, 2018 Released "Financial Report for the 3 rd Quarter of FY2017"
Jan. 11, 2018 Updated Top Message.
Nov. 9, 2017 J-TEC provides CDMO and CRO services for Cyfuse Biomedical K.K. (Regenerative Medicine Venture Company that Fujifilm invests in.)
Nov. 1, 2017 Updated Top Message.
Oct. 30, 2017 Updated Top Message.
Released "Financial Report for the 2 nd Quarter of FY2017".
Sep.27, 2017 J-TEC provides CDMO and CRO services for NC Medical Research, Inc. (Regenerative Medicine Venture Company that Fujifilm invests in.)
Aug. 23, 2017 Released Custom Development & Manufacturing Business contents.
Jul. 28, 2017 Released "Financial Report for the 1 st Quarter of FY2017"
Jun. 28, 2017 Updated Top Message.
The Annual J-TEC Stockholders Meeting took place on June 27th, and the Meeting approved the new BOD members. Updated Corporate Profile.
May.10, 2017 J-TEC provides CDMO and CRO services for Regcell Co., Ltd. (Regenerative Medicine Venture Company that Fujifilm invests in.)
Apr. 3, 2017 Updated Top Message.